volume (PVR) of DU patients, but a direct effect of Acotiamide on bladder is unknown.
INTRODUCTION AND OBJECTIVES:
Bladder outlet obstruction (BOO) promotes the hyperplasia of bladder detrusor, increases bladder pressure and decreases bladder compliance in clinic. To extensively explore its underlying mechanism, our study aims to investigate the effect of pathological hydrostatic pressure on the bladder smooth muscle cell (BSMC) proliferation and contraction through badrenoceptor (ADRB) signaling in vitro.
METHODS: Human bladder smooth muscle cells (hBSMCs) were treated with the pathological hydrostatic pressure (100 cm H2O), and CCK8, EdU, collagen gel contraction test, RT-PCR and western blot were employed to investigate the effect of ADRB on the proliferation and contraction of BSMCs that were treated with its agonist and/or antagonist.
RESULTS: Firstly, 100 cm H2O hydrostatic pressure significantly upregulated the expression of SMA-aAE of BMSCs at 6 h, however, promoted its proliferation at 24 h. hBSMCs treated with b2 and b3-adrenoceptor (ADRB2, ADRB3) agonists for 6 h under 100 cm H2O could inhibit the SMA-aAE expression when compared to the cells treated with hydrostatic pressure only, nevertheless, hBSMCs treated with ADRB2 agonists for 24 h under hydrostatic pressure could suppress the proliferation of cells when compared to the cells treated with hydrostatic pressure only. the two classical pathways PKA/EPAC of ADRB downstream played respectively role on the contraction and proliferation of hBSMCs under hydrostatic pressure. The PKA and EPAC pathways inhibited the contraction of hBSMCs under hydrostatic pressure via regulating SMAD2 activities, and EPAC showed a predominant role in hBSMC contraction. Furthermore, the proliferation of hBSMCs was mainly determined by EPAC pathway rather than PKA pathway through modulating ERK1/2 activities.
CONCLUSIONS: The contraction of hBSMCs under hydrostatic pressure was regulated by ADRB2, ADRB3 via PKA/EPAC-SMAD2 pathway, and the proliferation of hBSMCs under hydrostatic pressure were regulated by ADRB2 via EPAC-ERK1/2 pathways. Compared to ADRB3, ADRB2 play a predominant role under pathological hydrostatic pressure. These findings markedly unraveled the underlying mechanism of ADRB in BOO, and also provided a brandnew view for the efficient treatment of patients with BOO.
Source of Funding: This work was supported by the National Natural Science Foundation of China, grant nos. 81770673, 81470927; from 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University grant no. ZY2016104.
MP11-09 RAC1 INHIBITION BY EHT1864, NSC23766 OR BY KNOCKDOWN OF RAC1 EXPRESSION REDUCES PROLIFERATION AND ACTIN ORGANIZATION IN HUMAN BLADDER SMOOTH MUSCLE CELLS
Ruixao Wang*, Xiaolong Wang, Anna Ciotkowska, Beata Rutz, Alexander Tamalunas, Christian Gratzke, Christian G. Stief, Martin Hennenberg, Munich, Germany INTRODUCTION AND OBJECTIVES: Lower urinary tract symptoms (LUTS) include irritative symptoms caused by overactive bladder (OAB) and voiding symptoms caused by benign prostatic hyperplasia. Recently, a role of the small monomeric GTPase Rac1 has been suggested for prostate smooth muscle contraction and prostate growth, which are key factors contributing to voiding symptoms. A similar role of Rac1 appears possible for growth and contraction of smooth muscle cells in the bladder, which may contribute to LUTS attributed to OAB. Recently, pharmacologic studies using small molecule inhibitors suggested a function of Rac1 in detrusor contraction, but target validation by knockout or the role of Rac1 in detrusor growth have not been addressed so far. Here, we examined effects of Rac inhibition or Rac1 knockout on growth and actin organization in bladder smooth muscle cells.
METHODS: Experiments were carried out in cultured human bladder smooth muscle cells (hBSMCs). Rac inhibition was induced by small molecule inhibitors (NSC23766, EHT1864), or knockdown of Rac expression by lentiviral-based shRNA. Different readouts were applied to assess viability (CCK-8 assay), proliferation activity (EdU assay, colony formation, Ki-67 expression, FACS), actin organization (phalloidin staining), or to confirm knockout.
RESULTS: In wildtype hBSMCs, NSC23766 and EHT1864 reduced viability concentration-dependently. Low concentrations (25 μM EHT 1864, 50 μM NSC23766) showed only moderate effects on viability, but caused strong reductions of proliferation activity and increased apoptosis, as reflected by reduced proliferation index in EdU assay, reduced colony formation, and annexin-v FACS assay. Knockdown of Rac1 expression was induced by lentiviral shRNA, which was confirmed by RT-PCR and Western blot. Similar to small molecule inhibitors with assumed specificty for Rac, Rac1 knockdown resulted in reduced proliferation activity and increased apoptosis, as shown by EdU assay, analysis of Ki-67 content, and annexin-v FACS analysis. This was paralleled by reduced viability in CCK-8 assay. In control and wildtype cells, actin was organized to filaments forming long protrusion. Filament organization was widely reduced by NSC23766, EHT, and Rac1 knockdown.
